Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Other Chemical Drugs > Retatrutide for Sale > Retatrutide,loss weight;safe shipping;CAS:2381089-83-2;raw material
Retatrutide,loss weight;safe shipping;CAS:2381089-83-2;raw material buy - large image1
Retatrutide,loss weight;safe shipping;CAS:2381089-83-2;raw material buy - image1
Retatrutide,loss weight;safe shipping;CAS:2381089-83-2;raw material buy - image2
Retatrutide,loss weight;safe shipping;CAS:2381089-83-2;raw material buy - image3
Retatrutide,loss weight;safe shipping;CAS:2381089-83-2;raw material buy - image4
Retatrutide,loss weight;safe shipping;CAS:2381089-83-2;raw material buy - image5
Retatrutide,loss weight;safe shipping;CAS:2381089-83-2;raw material buy - image6

Retatrutide,loss weight;safe shipping;CAS:2381089-83-2;raw material

6909 Inquiries

Unit Price:

$160-175/UNIT FOB

Get Latest Price
CAS No.:

2381089-83-2

Grade:

Industrial Grade

Content:

99.89%

Port:

shenzhen

Brand:

QTS-RT

Packaging:

30mg*10vials

Price valid (until):

2026-12-31

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Retatrutide,Tirzepatide,GHK-Cu,TB500,Nad+

  • Product Description

  • Seller Information

  • Inquiry History

  • Description

    Name:Domi
    WhatsApp:+1 (763) 269-7596
    Email:domi@qtsbio.com

    Shop Retatrutide,loss weight;safe shipping;CAS:2381089-83-2;raw material-Detailed Image 1 Shop Retatrutide,loss weight;safe shipping;CAS:2381089-83-2;raw material-Detailed Image 2 Shop Retatrutide,loss weight;safe shipping;CAS:2381089-83-2;raw material-Detailed Image 3 Shop Retatrutide,loss weight;safe shipping;CAS:2381089-83-2;raw material-Detailed Image 4


       Product Detail  


    Items Specifications
    PRODUCT NAME PEPTIDE
    PURITY 99.86%
    PACKAGE 10VIALS/BOX
    STORAGE Store in a closed container in a cool, dry place, below 5 °C.
    RETEST 2 YEARS
    APPLICATION HEALTHCARE

    Retatrutide;GIPR/GLP-1R;LY3437943Retatrutide;Retalutide;Retatrutide (sodium salt);Retatrutide RT5;retatrutide 5mg;Retatratide
    Weight Loss Efficacy: According to Phase 2 trial data published in NEJM 2023, the 12mg dose group achieved an average weight loss of 24.2% over 48 weeks, with nearly half of patients losing ≥25% of body weight. The TRIUMPH-1 Phase 3 study announced at the 2026 ADA meeting showed that 104-week extended treatment achieved an average weight loss of 30.3% (approximately 85 pounds), with efficacy approaching bariatric surgery, and 65.3% of patients reduced BMI below 30 . Additional Health Benefits: Beyond weight loss, the drug significantly improves obesity-related comorbidities, including 73.1% reduction in knee osteoarthritis pain, 60.6% improvement in obstructive sleep apnea, 40% reduction in triglycerides, and 2.0% reduction in HbA1c . Safety Profile: The most common side effects are mild-to-moderate gastrointestinal reactions (nausea, diarrhea, vomiting), similar to other GLP-1/GIP drugs, with most resolving over time. The discontinuation rate for the highest dose group was 5.1% . Market Approval Progress: Eli Lilly plans to submit an application to the FDA in Q1 2027, and in August 2026 expanded its special access program to allow some severely obese patients unable to participate in clinical trials to apply for use


      Company Detail  


    Shop Retatrutide,loss weight;safe shipping;CAS:2381089-83-2;raw material-Detailed Image 5 Shop Retatrutide,loss weight;safe shipping;CAS:2381089-83-2;raw material-Detailed Image 6 Shop Retatrutide,loss weight;safe shipping;CAS:2381089-83-2;raw material-Detailed Image 7 Shop Retatrutide,loss weight;safe shipping;CAS:2381089-83-2;raw material-Detailed Image 8

    Beijing Quantaisheng Technology Co., Ltd offers variety of products which can meet your multifarious demands. We adhere to the management principles of "quality first, customer first and credit-based" since the establishment of the company and always do our best to satisfy potential needs of our customers. Our company is sincerely willing to cooperate with enterprises from all over the world in order to realize a win-win situation since the trend of economic globalization has developed with anirresistible force.


      Shipping Situation 


    Shop Retatrutide,loss weight;safe shipping;CAS:2381089-83-2;raw material-Detailed Image 9


    Shop Retatrutide,loss weight;safe shipping;CAS:2381089-83-2;raw material-Detailed Image 10


      Payment Method


    Shop Retatrutide,loss weight;safe shipping;CAS:2381089-83-2;raw material-Detailed Image 11


      FAQ


    Q1: What to do if there is damage during transportation?
    A: We offer comprehensive after-sales service. If you have any questions, please feel free to contact us at any time.

    Q2: Why choose your company?
    A:The price is competitive, the quality is stable, the delivery is prompt, the service is professional, and there is also a complete after-sales service.

    Q3: Which countries do you export to?
    A:Our products are exported to almost every corner of the world, including Europe, North America, South America, the Middle East and Southeast Asia. Please feel free to contact us at any time.

    Q4:What is your minimum order quantity (MOQ)?
    A:The minimum order quantity is usually 1box, which depends on the product model and customization requirements. For more details, please contact us.

    Q5: How long is your delivery lead time?
    It will generally be dispatched within 7-15 days. The exact time depends on your product model and quantity. Feel free to contact us at any time.

    Q: How to make the order?
    1) Let me know the items and quantity you need.
    2) Choose the payment methods you prefer.
    3) Send me the Recipient's info to arrange shipment.
    4) We will send you tracking number within 2 workdays.

    Q: How to confirm product quality before placing an order?
    A: All of our products comply with 99%+purity standards and tested in Janoshik lab. If you need, we can provide you with certificates.

    Q: Is there any discount?
    A: Different quantities have different discounts. 

    Q: How do you deal with quality complaints?
    A: First, our quality control will reduce quality issues to close to zero. If there are real quality problems caused by us, we will provide you with a free replacement or refund for your lost goods.

    ECHEMI Editorial Reference
    Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide inhibits human GCGR, GIPR and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively and mouse GCGR, GIPR, and GLP-1R with EC50 values of 2.32, 0.191 and 0.794 nM, respectively. It is an important tool for obesity research.Retatrutide potently activates the GLP-1R signaling pathway to stimulate glucose-dependent insulin secretion through activity at the GIP receptor (GIPR) or the GLP-1R.Retatrutide is a synthetic peptide with glucose-lowering effects. It is an antidiabetic agent against type 2 diabetes (T2D), stimulating insulin and suppressing glucagon secretion in a glucose-dependent manner.Retatrutide was also shown to delay gastric emptying, lower fasting and postprandial glucose concentration, decrease food intake and reduce body weight in patients with type 2 diabetes.

    Basic Info
    Product Name:

    Retatrutide

    Other Name:

    Retatrutide;GIPR/GLP-1R;LY3437943Retatrutide;Retalutide;Retatrutide (sodium salt);Retatrutide RT5;retatrutide 5mg;Retatratide

    CAS No.:

    2381089-83-2

    Molecular Formula:

    C221H342N46O68

    InChIKeys:

    MLOLQJNKXBNWFW-SAGGEDDASA-N

    Molecular Weight:

    4731.33

    EC Number:

    200-001-8

    Color/Form:

    White lyophilized

    Categories:

    Other Chemical Drugs

    Characteristics
    Water Solubility:

    Soluble in water (5mg/ml).

    Storage Conditions:

    -20°C

    Critical Temperature & Pressure:

    -20°C

    Research
    Class:

    Triple agonist — GCGR, GIPR, GLP-1R

    Status:

    Investigational (Phase 3)

    Mechanism:

    Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.

    EC50 (Human GCGR):

    5.79 nM

    EC50 (Mouse GIPR):

    0.191 nM

    EC50 (Mouse GLP1R):

    0.794 nM

    EC50 (Mouse GCGR):

    2.32 nM

    EC50 (Human GLP1R):

    0.775 nM

    EC50 (Human GIPR):

    0.0643 nM

    Source:

    Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI

    Clinical Development:

    NCT04881760; NCT05882045; NCT06354660

    References
    ChEMBL:

    CHEMBL5095485

    DrugBank:

    DB18993

    KEGG DRUG:

    D12430

    PubChem:

    PubChem

    Disclaimer:

    Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Retatrutide,Tirzepatide,GHK-Cu,TB500,Nad+

    Location:

    Beijing

    Year of Establishment:

    2026

  • Inquiry History
    6909 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Retatrutide 2381089-83-2

    3 MT Mar 28, 2026
    United Kingdom

    Retatrutide - 2381089-83-2

    1 G Feb 10, 2026
    United States

    Retatrutide CAS 2381089-83-2 10mg vial

    20 MT Mar 7, 2026
    United States

    Factory Retatrutide API 99% Purity CAS 2381089-83-2

    5 KG Nov 10, 2025
    United Kingdom

    Peptide powder Retatrutide 99% pure for Body building cas 2381089-83-2 Weight Loss Peptide with COA

    1 MT Mar 22, 2026
    United States

    2381089-83-2

    100 G Jul 14, 2026
    United States

    2381089-83-2

    100 G Feb 24, 2026
    United States

    2381089-83-2

    100 MT Dec 9, 2023
    United States

    Retatrutide 2381089-83-2

    200 MG May 16, 2026
    United Kingdom

    2381089-83-2 retatrutide

    300 MG Feb 13, 2026
    United States

    Retatrutide 2381089-83-2 wholesale

    500 MT Nov 3, 2023
    United States

    Retatrutide CAS 2381089-83-2 99%

    10 PCS Feb 21, 2026
    Poland

    CAS 2381089-83-2 (Custom Peptide)

    40 MT Apr 10, 2026
    Austria

    Peptide Retatruide CAS 2381089-83-2

    100 MT Apr 4, 2026
    Austria

    Retatrutide CAS 2381089-83-2 10mg vial

    20 PCS Feb 10, 2026
    United States

    GLP-1 / GIP Retatrutide cas 2381089-83-2

    1 MT Oct 16, 2024
    United States

    Retatrutide 99% High Quality CAS 2381089-83-2

    1 G Jan 23, 2026
    United States

    Injection Peptide Tirzepatide/Retatrutide/ Semaglutide Peptides CAS 2381089-83-2

    10  Oct 21, 2023
    Palestine

    Factory 99% Purity Retatrutide Peptide CAS 2381089-83-2 Door-To-Door Service

    10 MG Mar 16, 2026
    United States

    Factory 99% Purity Retatrutide Peptide CAS 2381089-83-2 Door-To-Door Service

    20 MG Feb 4, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.